NEO
Phase 1- Indications
- Spinal cord injury, Neurological disorders
Company intelligence / Profile preview
Neuracle Technology Co., Ltd., also known simply as "Neuracle," develops advanced portable neurophysiological recording and stimulation equipment—including EEG, EMG, ERP, and transcranial electrical stimulation systems—for global neuroscience researchers and clinicians. The company’s products are widely adopted across academia due to their integration capabilities with third-party hardware/software solutions. While they do not develop therapeutics themselves nor run drug trials, their technologies play an important role in neurological diagnostics/research worldwide through high-quality device offerings backed by decades of R&D experience from the founding team based primarily out of China’s innovation hubs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neuracle Technology.